MicrobiologybioRxiv
Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 in vitro
N. Drayman, K. A. Jones, S.-A. Azizi…·S. Tay
The paper screens 1,900 drugs to find inhibitors of SARS-CoV-2 replication, identifies masitinib as a 3CLpro inhibitor effective in vitro, and shows its broad anti-viral activity.
DOI 10.1126/science.abg5827